Product: Medical and Aesthetic Laser Treatment Company: Lumenis Year of Foundation: 1966
Laser is a source of concentrated radiation that, since its discovery in the 1960s, has been implemented in a variety of uses. Thanks to Israel’s developed military industry, as early as 1966, its graduates developed a medical use for the laser with a pioneering technology for treating damage to the retina caused by diabetes.
This treatment, along with 250 subsequent patents registered by the company, changed the face of global medicine and replaced the surgeon’s scalpel with a swift, clean, lower risk procedure. Laser is capable of performing precise incisions on the desired tissue according to specific medical need. Lumenis specializes in the development of devices intended for use in a wide range of fields including aesthetic treatment of skin, hair, pigmentation and scars and surgical procedures such as ophthalmology, gynecology, ENT and urology. The varied use of the laser in the medical and aesthetic fields is made possible by virtue of its varying wavelengths. Each wavelength has a separate absorption range that enables selective treatment.
Lumenis’s expertise in clinical solutions for a wide range of fields has gained dozens of FDA approvals and made a significant medical impact in approximately 100 countries, in both the public and private sectors. The clinical advantages of the company’s devices are documented in hundreds of scientific publications and presented on the stages of the world’s leading conferences.
In the 1990s, the company launched a range of innovative technologies such as holmium lasers, for treating kidney or urinary tract stones; CO2 laser for advanced skin treatments and arthroscopic surgery; SLT laser for treating glaucoma; and IPL technology for skin treatment and hair removal.
In 2017, Lumenis caused a revolution in the world of urology when it launched ‘Moses’ – a groundbreaking patent that redefines the manner in which laser is used in lithotripsy (shattering kidney or urinary tract stones). This technology enables a more effective transfer of energy, thereby affording the surgeon better control in a shorter medical procedure.
Lumenis has adopted the motto of innovation and improving people’s lives, both locally and around the world, and continues to do so from its R&D base in Israel.
